Multicenter observational study on the connection between sarcopenia and the curability of chemotherapy in advanced or recurrent colorectal cancer.

Multicenter observational study on the connection between sarcopenia and the curability of chemotherapy in advanced or recurrent colorectal cancer. - Multicenter observational study on the connection between sarcopenia and the curability of chemotherapy in advanced or recurrent colorectal cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027558

Enrollment

249

Registered

2017-05-31

Start date

2017-05-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The patient is found to have colorectal cancer histopathologically. 2. The tumor is too progressive or reccurent and no resectable. It is judged by the attending doctor. 3. First line systemic chemotherapy is administered. 4. The patients registered in KSCC0701, 0801, 0802, 0902, 1002, 1101 have the image of CT before the start of chemotherapy and 60 to 120 days or 150 to 210 after chemotherapy.

Exclusion criteria

Exclusion criteria: It is the excluded case that is judged irreverent by the attending doctor.

Design outcomes

Primary

Measure	Time frame
The primary outcomes are Overall survival period, relapse free survival period, response rate, Adverse event rate. We are going to investigate the correration the sarcopenia, the rate of skeletal muscle loss and subcutaneous or visceral fat with the primary outcomes.	—

Countries

Japan

Contacts

Public ContactKSCC Research Secretariat

Kyushu Study group of Clinical Cancer KSCC Research Secretariat

sanae.sakamoto@ks-cc.or.jp092-409-3500

Outcome results